Biblio
. Stem Cell Res. 2018;34:101344.
Cardiac glycoside ouabain efficiently targets leukemic stem cell apoptotic machinery independent of cell differentiation status. Cell Commun Signal. 2023;21(1):283.
. CRISPR/Cas9 mediated approach to generate YAP-depleted human embryonic stem cell line (MUSIe002-A-1). Stem Cell Res. 2022;66:102990.
. Derivation of human embryonic stem cell line MUSIe001-A from an embryo with homozygous α-thalassemia (SEA deletion). Stem Cell Res. 2020;43:101695.
. Episomal vector reprogramming of human umbilical cord blood natural killer cells to an induced pluripotent stem cell line MUSIi013-A. Stem Cell Res. 2021;55:102472.
. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors. Stem Cell Res. 2018;32:43-46.
. Generation of a serine/threonine-protein kinase LATS1 gene-edited iPSC MUSIi012-A-3. Stem Cell Res. 2020;48:101950.
. .
.
Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations. Cell Transplant. 2020;29:963689720965900.
. Role of YAP in hematopoietic differentiation and erythroid lineage specification of human-induced pluripotent stem cells. Stem Cell Res Ther. 2023;14(1):279.
. YAP-depleted iPSC MUSIi012-A-2 maintained all normal stem cell characteristics. Stem Cell Res. 2020;43:101723.